GCC Intravenous Solutions Market Report by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids), and Country 2024-2032

GCC Intravenous Solutions Market Report by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids), and Country 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A2943
Buy Now

Market Overview:

The GCC intravenous solutions market size reached US$ 743.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,184.6 Million by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. The growing cases of gastrointestinal disorders, AIDS, obesity, and diabetes among the masses, ongoing improvements in supply chain infrastructure and distribution networks, and continual technological advancements in medical research are among the key factors driving the market growth.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
US$ 743.6 Million
Market Forecast in 2032
US$ 1,184.6 Million
Market Growth Rate 2024-2032 5.2%


Intravenous (IV) solutions are sterile liquids administered directly into a patient's bloodstream through a vein. These solutions play a crucial role in medical care, serving various purposes such as rehydration, nutrient delivery, medication administration, and electrolyte balance restoration. IV solutions are tailored to meet specific patient needs, with various types available, each serving a distinct purpose. Isotonic solutions have a similar concentration of electrolytes as bodily fluids and are used to maintain fluid balance, while hypotonic solutions have a lower electrolyte concentration and help rehydrate cells. Conversely, hypertonic solutions possess a higher electrolyte content and are employed to draw fluids out of cells. IV solutions are employed in diverse medical settings, including hospitals, clinics, and ambulances, aiding in critical situations such as surgery recovery, trauma care, and fluid loss due to illness.

The growing cases of gastrointestinal disorders, AIDS, obesity, and diabetes among the masses are driving the market in GCC. Moroever, the hot climate in several GCC countries, especially during the summer months, can lead to a higher incidence of dehydration. IV solutions are commonly used to rehydrate individuals quickly and effectively. Besides, the concept of home healthcare has been growing in the GCC region. Patients who require ongoing IV treatments may opt for home-based care, leading to an increased demand for IV solutions and related equipment. Furthermore, continual advancements in medical research and technology have led to the development of new IV therapies and solutions. The adoption of these innovative treatments in the GCC region could contribute to market growth. Additionally, ongoing improvements in supply chain infrastructure and distribution networks ensure that medical supplies, including IV solutions, are efficiently delivered to healthcare facilities across the GCC region.

GCC Intravenous Solutions Market Trends/Drivers:

Growing Healthcare Infrastructure and Demand for Medical Interventions

As healthcare systems advance, there is a corresponding need for efficient and accessible methods of administering fluids, medications, and nutrients. Intravenous solutions provide a direct route for delivering critical substances into the bloodstream, enabling rapid response in emergency situations and precise dosing for various therapies. With the rise in chronic diseases, surgeries, and trauma cases, the demand for intravenous solutions has increased, as these solutions are indispensable for patient stabilization, post-operative care, and disease management. Moroever, the establishment of modern hospitals, clinics, and ambulatory centers necessitates a reliable supply of IV fluids to cater to a diverse range of medical requirements. Additionally, the growing elderly population, who often require complex medical interventions and continuous medication, further augments the demand for intravenous solutions.

Increasing Prevalence of Chronic Diseases and Surgical Procedures

Chronic conditions such as diabetes, cardiovascular diseases, and cancer often require ongoing treatment regimens involving IV medications and fluids. These conditions necessitate a consistent supply of intravenous solutions to manage symptoms, administer pain relief, and ensure adequate hydration and nutrition. As a result, the growing incidence of chronic illnesses has created a sustained demand for IV solutions across various healthcare settings. Furthermore, surgical interventions, whether elective or emergent, rely heavily on intravenous solutions for perioperative care and post-operative recovery. IV fluids are crucial in maintaining patient stability during surgery, replacing fluid losses, and preventing complications. After surgery, IV solutions aid in the patient's healing process, supporting tissue repair, and maintaining optimal physiological conditions.

GCC Intravenous Solutions Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the GCC intravenous solutions market report, along with forecasts at the regional and country levels from 2024-2032. Our report has categorized the market based on type and nutrients.

Breakup by Type:

Total parenteral nutrition holds the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes partial parenteral nutrition, and total parenteral nutrition. According to the report, total parenteral nutrition represented the largest segment.

Total parenteral nutrition plays a pivotal role in addressing malnutrition, supporting recovery after major surgeries, and managing conditions such as Crohn's disease, cancer, and severe burns. The growing prevalence of chronic diseases and conditions that impede normal nutrient absorption has amplified the demand for TPN as a life-sustaining therapy. Moreover, advancements in medical technology and the formulation of TPN solutions have led to improved patient outcomes, reducing the risks associated with malnutrition and complications arising from nutritional deficiencies. Furthermore, the aging population and the subsequent rise in complex medical cases have further catalyzed the demand for TPN. Elderly individuals, who may experience difficulties in eating, swallowing, or nutrient absorption, often require specialized nutritional support delivered intravenously. Additionally, the expansion of healthcare facilities, coupled with increasing awareness about the benefits of TPN among healthcare professionals, has fueled its adoption and contributed to its dominant position within the intravenous solutions market.

Breakup by Nutrients:

  • Carbohydrates
  • Salts and Electrolytes
  • Minerals
  • Vitamins
  • Amino Acids
     

Amino acids holds the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the nutrients. This includes carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids. According to the report, amino acids represented the largest segment.

Amino acids referred to as the building blocks of proteins, play an indispensable role in various physiological processes, including tissue repair, immune response, and enzymatic activity. The prominence of amino acids as the largest nutrient segment can be attributed to their fundamental role in promoting healing, maintaining muscle mass, and supporting metabolic functions. Patients recovering from surgeries, trauma, or critical illnesses often experience heightened protein catabolism, which necessitates an increased supply of amino acids to facilitate tissue regeneration and counteract muscle breakdown. Furthermore, individuals with chronic diseases, such as kidney disorders, may require precise administration of amino acids to manage their condition effectively. Amino acids also serve as a cornerstone in the management of malnutrition, a condition prevalent in various healthcare settings. When oral or enteral nutrition is compromised, intravenous administration of amino acids becomes crucial for sustaining adequate protein intake and averting further deterioration.

Breakup by Country:

  • Saudi Arabia
  • UAE
  • Qatar
  • Oman
  • Kuwait
  • Bahrain
     

Saudi Arabia exhibits a clear dominance, accounting for the largest GCC intravenous solutions share

The report has also provided a comprehensive analysis of all the major country markets, which include Saudi Arabia, UAE, Qatar, Oman, Kuwait and Bahrain. According to the report, Saudi Arabia accounted for the largest market share.

Saudi Arabia has made substantial investments in healthcare infrastructure and facilities, resulting in a robust and modern healthcare system. This includes state-of-the-art hospitals, clinics, and specialized medical centers that require a consistent and substantial supply of intravenous solutions to cater to the needs of its growing population. Furthermore, the country's commitment to providing high-quality healthcare to its citizens and residents has led to a steady demand for intravenous solutions across various medical disciplines. Saudi Arabia's healthcare policies prioritize advanced medical interventions, and intravenous solutions are an integral part of critical care, surgical procedures, and long-term disease management. Moreover, Saudi Arabia's position as an economic powerhouse in the region has provided the resources necessary to invest in cutting-edge medical technologies and pharmaceutical manufacturing capabilities. This enables the country to not only meet its domestic demand but also export intravenous solutions to neighboring nations, further solidifying its dominance in the market.

Competitive Landscape:

Companies are heavily investing in research and development to develop new formulations, improve existing products, and create innovative intravenous solutions that cater to specific medical conditions. This includes exploring novel additives, delivery systems, and packaging options to enhance the safety, efficacy, and convenience of IV solutions. Moreover, several companies are expanding their product offerings to cover a broader range of intravenous solutions. They are developing solutions that cater to different patient demographics, including pediatrics, geriatrics, and patients with specific medical needs such as diabetes, oncology, and critical care. With a growing emphasis on personalized medicine, companies are working to provide intravenous solutions that are tailored to individual patient requirements. This involves formulating solutions that consider patient factors, including age, weight, medical condition, and specific nutrient needs. Leading players are integrating advanced technology into intravenous delivery systems. This includes the development of smart infusion pumps that offer accurate dosing, real-time monitoring, and alerts for potential errors.

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

GCC Intravenous Solutions Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
  • Type
  • Nutrients
  • Country
Types Covered Partial Parenteral Nutrition, Total Parenteral Nutrition
Nutrients Covered Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids
Countries Covered Saudi Arabia, UAE, Qatar, Oman, Kuwait, Bahrain
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the GCC intravenous solutions market from 2018-2032.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the GCC intravenous solutions market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the GCC intravenous solutions industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Key Questions Answered in This Report

The GCC intravenous solutions market was valued at US$ 743.6 Million in 2023.

We expect the GCC intravenous solutions market to exhibit a CAGR of 5.2% during 2024-2032.

The increasing prevalence of chronic diseases, along with the escalating demand for intravenous solutions, as they provide faster response time and higher efficacy than other drug delivery systems, is primarily driving the GCC intravenous solutions market.

The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of intravenous solutions for providing essential nutrients to patients in the Intensive Care Unit (ICU).

Based on the type, the GCC intravenous solutions market has been segregated into partial parenteral nutrition and total parenteral nutrition. Currently, total parenteral nutrition exhibits clear dominance in the market.

Based on the nutrients, the GCC intravenous solutions market can be bifurcated into carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids. Among these, amino acids hold the largest market share.

On a regional level, the market has been classified into Saudi Arabia, UAE, Qatar, Oman, Kuwait, and Bahrain, where Saudi Arabia currently dominates the GCC intravenous solutions market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
GCC Intravenous Solutions Market Report by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids), and Country 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More